Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:SOLARAConsumer Durables
Clear all filters
Q4 Results LIVE Updates: JSW Steel, Muthoot react to results; Tata Steel, Power Grid report today
positive
CNBC TV18 - Markets 57d ago

Q4 Results LIVE Updates: JSW Steel, Muthoot react to results; Tata Steel, Power Grid report today

Q4 Results LIVE Updates: Two Nifty 50 companies Tata Steel and Power Grid along with broader market names like ITC Hotels, Hindustan Copper, Godfrey Phillips, Gland Pharma, Cochin Shipyard, Deepak Nitrite, Balrampur Chini, Arvind, Bajaj Electricals, Aarti Drugs, Aether Industries, Alembic Pharma, NCC, NHPC, Premier Energies, SAIL, SJVN, Solara Active Pharma, Symphony, Thangamayil, Triveni Engineering, VST Tillers, are among the companies reporting their earnings today. JSW Steel, Muthoot Finance, Apollo Tyres, Endurance Tech, Voltas, are some of the other result reactions today. Watch this space for all the LIVE updates.

AARTIDRUGSAARTIINDABHAPOWERAETHERALEMBICLTDALLETECAONETMMQ50AONETOTALAPOLLOAPOLLOTYREAPOLSINHOTARVINDBAJAJELECBAJAJHFLBAJAJSTBAJFINANCEBALRAMCHINBANKBETFCOCHINSHIPDEEPAKNTRENDURANCEGLANDGODFRYPHLPGVPILHGINFRAHINDCOPPERITCITCHOTELSJSWHLJSWINFRAJSWSTEELLIQUIDBETFLTFMBELMOCAPITALMSPLMUTHOOTFINNCCNETFNHPCNIFTYBETFNPBETPARTHPFCPHARMABEESPOWERGRIDPREMIERPREMIERENESAILSALSTEELSJVNSOLARASYMPHONYTATAPOWERTATASTEELTATATECHTECHTNIDETFTRIVENIVIVIANAVOLTASVSTINDZTECHAutomobile and Auto ComponentsCapital Goods
Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing
positive
ET Markets - Industry 141d ago

Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing

Sai Life Sciences will boost its workforce by over 700 employees next financial year. This expansion supports growing global demand for its services. The company is increasing capacity to meet this demand. New hires will focus on scientific, technical, and management roles. This move reflects a broader trend of global pharma companies expanding in India.

ABSLNN50ETALIVUSFOCUSGLOBALGSEC10ABSLJFLLIFEJMFINANCILNAM-INDIARPGLIFESAILIFESOLARASUVENConsumer DurablesConsumer Services
Aurobindo Pharma shares in focus on USFDA approval for Tofacitinib tablets
positive
Moneycontrol NaNd ago

Aurobindo Pharma shares in focus on USFDA approval for Tofacitinib tablets

Aurobindo Pharma Share Price | The approved product is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis, active psoriatic arthritis, and moderately to severely active ulcerative colitis (UC).

AUROPHARMAFOCUSSOLARAConsumer DurablesHealthcare